- Home
- CALC
CALC
CalciMedica Inc.
as 04-23-2025 4:00pm EST
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | LA JOLLA |
| Market Cap: | 25.2M | IPO Year: | N/A |
| Target Price: | $16.33 | AVG Volume (30 days): | 60.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.45 - $6.27 | Next Earning Date: | 05-12-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest CalciMedica Inc. News
CALC Breaking Stock News: Dive into CALC Ticker-Specific Updates for Smart Investing
PR Newswire
7 days ago
CalciMedica Announces Presentations at Upcoming Medical Meetings
PR Newswire
23 days ago
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference
PR Newswire
a month ago
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates
PR Newswire
2 months ago
CalciMedica Secures Credit Facility for Up to $32.5 Million
PR Newswire
2 months ago
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference
PR Newswire
2 months ago
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference
PR Newswire
3 months ago
CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
PR Newswire
3 months ago
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
Compare CALC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CALC CalciMedica Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.